Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

705 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Galectin-3 and post-myocardial infarction cardiac remodeling.
Meijers WC, van der Velde AR, Pascual-Figal DA, de Boer RA. Meijers WC, et al. Among authors: de boer ra. Eur J Pharmacol. 2015 Sep 15;763(Pt A):115-21. doi: 10.1016/j.ejphar.2015.06.025. Epub 2015 Jun 19. Eur J Pharmacol. 2015. PMID: 26101067 Review.
Efficacy of angiotensin II type 1 receptor blockade on reperfusion-induced arrhythmias and mortality early after myocardial infarction is increased in transgenic rats with cardiac angiotensin II type 1 overexpression.
de Boer RA, van Geel PP, Pinto YM, Suurmeijer AJ, Crijns HJ, van Gilst WH, van Veldhuisen DJ. de Boer RA, et al. J Cardiovasc Pharmacol. 2002 Apr;39(4):610-9. doi: 10.1097/00005344-200204000-00017. J Cardiovasc Pharmacol. 2002. PMID: 11904535
Erythropoietin in cardiac disease: new features of an old drug.
Ruifrok WP, de Boer RA, Westenbrink BD, van Veldhuisen DJ, van Gilst WH. Ruifrok WP, et al. Among authors: de boer ra. Eur J Pharmacol. 2008 May 13;585(2-3):270-7. doi: 10.1016/j.ejphar.2008.01.054. Epub 2008 Mar 15. Eur J Pharmacol. 2008. PMID: 18407263 Review.
Galectin-3 in cardiac remodeling and heart failure.
de Boer RA, Yu L, van Veldhuisen DJ. de Boer RA, et al. Curr Heart Fail Rep. 2010 Mar;7(1):1-8. doi: 10.1007/s11897-010-0004-x. Curr Heart Fail Rep. 2010. PMID: 20425490 Free PMC article. Review.
Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial.
Lexis CP, van der Horst IC, Lipsic E, van der Harst P, van der Horst-Schrivers AN, Wolffenbuttel BH, de Boer RA, van Rossum AC, van Veldhuisen DJ, de Smet BJ; GIPS-III Investigators. Lexis CP, et al. Among authors: de boer ra, de smet bj. Cardiovasc Drugs Ther. 2012 Oct;26(5):417-26. doi: 10.1007/s10557-012-6413-1. Cardiovasc Drugs Ther. 2012. PMID: 22968678 Free PMC article. Clinical Trial.
A genome-wide association study of circulating galectin-3.
de Boer RA, Verweij N, van Veldhuisen DJ, Westra HJ, Bakker SJ, Gansevoort RT, Muller Kobold AC, van Gilst WH, Franke L, Mateo Leach I, van der Harst P. de Boer RA, et al. PLoS One. 2012;7(10):e47385. doi: 10.1371/journal.pone.0047385. Epub 2012 Oct 9. PLoS One. 2012. PMID: 23056639 Free PMC article.
705 results